| pubmed-article:2251896 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2251896 | lifeskim:mentions | umls-concept:C0033697 | lld:lifeskim |
| pubmed-article:2251896 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:2251896 | lifeskim:mentions | umls-concept:C0020964 | lld:lifeskim |
| pubmed-article:2251896 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:2251896 | pubmed:dateCreated | 1991-1-16 | lld:pubmed |
| pubmed-article:2251896 | pubmed:abstractText | The dynamics of the formation of postvaccinal immunity after immunization with preparations obtained with the use of hydroxylamine (HA) preparations from Proteus strains of different O serogroups, Salmonella minnesota Re-mutant and the common antimicrobial antigen isolated from Escherichia coli 14 has been studied on mice with Proteus peritonitis-bacteremia used as a model. The study has revealed that intraperitoneal immunization with Proteus HA preparations stimulates the phagocytic activity of peritoneal mononuclear cells in mice and induces an increase in the titers of specific O antibodies. Proteus antigens ensure the formation of anti-Proteus immunity, preventing the death of the animals from peritonitis-bacteremia. The protection of mice from such infection resulting from the injection of the common antigens of gram-negative bacteria is considerably less. These data are indicative of the possibility of using Proteus peritonitis-bacteremia as a model for the study of the protective potency of Proteus vaccines. | lld:pubmed |
| pubmed-article:2251896 | pubmed:language | rus | lld:pubmed |
| pubmed-article:2251896 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2251896 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2251896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2251896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2251896 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2251896 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:2251896 | pubmed:issn | 0372-9311 | lld:pubmed |
| pubmed-article:2251896 | pubmed:author | pubmed-author:LevinaL ALA | lld:pubmed |
| pubmed-article:2251896 | pubmed:author | pubmed-author:Za?tsevE VEV | lld:pubmed |
| pubmed-article:2251896 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2251896 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2251896 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2251896 | pubmed:pagination | 74-8 | lld:pubmed |
| pubmed-article:2251896 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:meshHeading | pubmed-meshheading:2251896-... | lld:pubmed |
| pubmed-article:2251896 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2251896 | pubmed:articleTitle | [Proteus peritonitis-bacteremia in mice--a model for studying postvaccinal Proteus immunity]. | lld:pubmed |
| pubmed-article:2251896 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2251896 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2251896 | pubmed:publicationType | English Abstract | lld:pubmed |
